Cardiovascular disease and its management in children and adults undergoing hematopoietic stem cell transplantation

SJ Rotz, TD Ryan, SS Hayek - Journal of thrombosis and thrombolysis, 2021 - Springer
Hematopoietic stem cell transplantation (HSCT) is a potentially curative treatment for many
malignancies, hemoglobinopathies, metabolic diseases, bone marrow failure syndromes …

[HTML][HTML] National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-Host disease: IV. the 2020 highly morbid forms …

D Wolff, V Radojcic, R Lafyatis, R Cinar… - … and cellular therapy, 2021 - Elsevier
Chronic graft-versus-host disease (GVHD) can be associated with significant morbidity, in
part because of nonreversible fibrosis, which impacts physical functioning (eye, skin, lung …

Total body irradiation in haematopoietic stem cell transplantation for paediatric acute lymphoblastic leukaemia: review of the literature and future directions

BAW Hoeben, JYC Wong, LS Fog, C Losert… - Frontiers in …, 2021 - frontiersin.org
Total body irradiation (TBI) has been a pivotal component of the conditioning regimen for
allogeneic myeloablative haematopoietic stem cell transplantation (HSCT) in very-high-risk …

Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell …

E Brissot, M Labopin, I Moiseev, JJ Cornelissen… - Journal of hematology & …, 2020 - Springer
Background Graft-versus-host disease (GVHD) remains a major contributor to mortality and
morbidity after allogeneic stem-cell transplantation (allo-HSCT). The updated …

Minor histocompatibility antigen-specific T cells

C Summers, VS Sheth, M Bleakley - Frontiers in Pediatrics, 2020 - frontiersin.org
Minor Histocompatibility (H) antigens are major histocompatibility complex (MHC)/Human
Leukocyte Antigen (HLA)-bound peptides that differ between allogeneic hematopoietic stem …

Low-dose post-transplant cyclophosphamide with low-dose antithymocyte globulin for prevention of graft-versus-host disease in first complete remission undergoing …

Y Zu, Z Li, R Gui, Y Liu, Y Zhang, F Yu, H Zhao… - Bone Marrow …, 2022 - nature.com
The most widely used regimens of graft-versus-host disease (GVHD) prophylaxis in HLA-
matched unrelated donor peripheral blood stem cell transplantation (MUD-PBSCT) are …

[HTML][HTML] Towards homogenization of total body irradiation practices in pediatric patients across SIOPE affiliated centers. A survey by the SIOPE radiation oncology …

BAW Hoeben, M Pazos, MH Albert, E Seravalli… - Radiotherapy and …, 2021 - Elsevier
Background and purpose To reduce relapse risk, Total Body Irradiation (TBI) is part of
conditioning regimens for hematopoietic stem cell transplantation (HSCT) in pediatric acute …

Long-term outcomes among adolescent and young adult survivors of acute leukemia: a surveillance, epidemiology, and end results analysis

AM Berkman, CR Andersen, B Cuglievan… - … Biomarkers & Prevention, 2022 - AACR
Background: There is a growing population of adolescent and young adult (AYA, age 15–39
years) acute leukemia survivors in whom long-term mortality outcomes are largely unknown …

Low-dose anti-thymocyte globulin plus low-dose post-transplant cyclophosphamide-based regimen for prevention of graft-versus-host disease after haploidentical …

X Li, J Yang, Y Cai, C Huang, X Xu, H Qiu… - Frontiers in …, 2023 - frontiersin.org
Introduction The novel low-dose anti-thymocyte (ATG, 5 mg/kg) plus low-dose post-
transplant cyclophosphamide (PTCy, 50 mg/kg)(low-dose ATG/PTCy)-based regimen had …

[HTML][HTML] Comparison of total body irradiation versus non-total body irradiation containing regimens for de novo acute myeloid leukemia in children

CE Dandoy, SM Davies, KW Ahn, Y He, AE Kolb… - …, 2021 - ncbi.nlm.nih.gov
With limited data comparing hematopoietic cell transplant outcomes between myeloablative
total body irradiation (TBI) containing and non-TBI regimens in children with de novo acute …